The stock of Revolution Medicines Inc (RVMD) has seen a -6.93% decrease in the past week, with a -2.17% drop in the past month, and a -3.12% decrease in the past quarter. The volatility ratio for the week is 5.39%, and the volatility levels for the past 30 days are at 4.14% for RVMD. The simple moving average for the last 20 days is -7.58% for RVMD’s stock, with a simple moving average of -14.84% for the last 200 days.
Is It Worth Investing in Revolution Medicines Inc (NASDAQ: RVMD) Right Now?
Company’s 36-month beta value is 1.08.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 4 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for RVMD is 161.88M, and currently, short sellers hold a 11.22% ratio of that floaft. The average trading volume of RVMD on June 30, 2025 was 1.99M shares.
RVMD) stock’s latest price update
Revolution Medicines Inc (NASDAQ: RVMD)’s stock price has gone decline by -1.52 in comparison to its previous close of 37.48, however, the company has experienced a -6.93% decrease in its stock price over the last five trading days. reuters.com reported 2025-06-24 that Royalty Pharma said on Tuesday will pay up to $2 billion to Revolution Medicines to support the companies’ plans for global development and commercialization of the experimental cancer drug daraxonrasib.
Analysts’ Opinion of RVMD
Many brokerage firms have already submitted their reports for RVMD stocks, with Needham repeating the rating for RVMD by listing it as a “Buy.” The predicted price for RVMD in the upcoming period, according to Needham is $62 based on the research report published on July 16, 2024 of the previous year 2024.
Barclays, on the other hand, stated in their research note that they expect to see RVMD reach a price target of $52. The rating they have provided for RVMD stocks is “Overweight” according to the report published on July 12th, 2024.
Jefferies gave a rating of “Buy” to RVMD, setting the target price at $63 in the report published on July 08th of the previous year.
RVMD Trading at -6.45% from the 50-Day Moving Average
After a stumble in the market that brought RVMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.85% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RVMD starting from Cislini Jeff, who sale 1,912 shares at the price of $39.61 back on Jun 20 ’25. After this action, Cislini Jeff now owns 54,093 shares of Revolution Medicines Inc, valued at $75,736 using the latest closing price.
Stock Fundamentals for RVMD
Current profitability levels for the company are sitting at:
- -3.02 for the present operating margin
- 0.45 for the gross margin
The net margin for Revolution Medicines Inc stands at -2.67. The total capital return value is set at -0.36. Equity return is now at value -36.68, with -32.64 for asset returns.
Based on Revolution Medicines Inc (RVMD), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -4.4.
Currently, EBITDA for the company is -589.02 million with net debt to EBITDA at 0.26. When we switch over and look at the enterprise to sales, we see a ratio of 25.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.46.
Conclusion
In a nutshell, Revolution Medicines Inc (RVMD) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
